Jill and Kaj talking on his podcast

KAJ Masterclass Live

Byjsitnick

A Journey from Corporate Life to Psychedelic Advocacy

Jill Sitnick spent 25 years in edtech, working for major companies like Microsoft and Amazon. But everything changed after the loss of her long-term partner and a PTSD diagnosis at 47. Talk therapy wasn’t working. Her breakthrough came when her therapist introduced her to MDMA-assisted therapy. After three guided sessions, Jill no longer met the clinical criteria for PTSD. Now, she’s an outspoken advocate, pushing for global access to psychedelic-assisted psychotherapy.

What Makes MDMA Therapy Different?

  • Rapid Results: Clinical trials show that 3 out of 4 participants no longer qualify for a PTSD diagnosis after just three sessions.
  • Holistic Healing: Unlike traditional antidepressants, MDMA allows patients to confront and process trauma in a supported setting.
  • Non-addictive: MDMA is not habit-forming when used therapeutically.
  • Deep Emotional Work: Sessions are 5–8 hours long and occur with trained professionals in a safe environment.

“This isn’t about tripping. This is about healing.” – Jill Sitnick

Why Traditional Therapies Often Fall Short

Jill shared that her PTSD went undiagnosed for years. She coped through high performance and a stable relationship. It wasn’t until the emotional support of her partner was gone that she hit a breaking point. Despite months of talk therapy and antidepressants, her panic symptoms worsened.

  • Flashbacks and physical anxiety symptoms emerged.
  • Talk therapy wasn’t effective in resolving core trauma memories.
  • MDMA therapy created the emotional safety needed to explore those memories.

What Was Jill’s MDMA Therapy Like?

  • Preparation: She underwent psychological and physical screening.
  • Delivery: The MDMA was taken in pill form, in a controlled setting with a therapist and medical doctor present.
  • Session Length: 5 to 8 hours per journey.
  • Integration: Post-session therapy and reflection were critical.
  • Side Effects: Mild emotional fatigue and need for rest, no long-term adverse effects.

“It calmed my nervous system and helped me see my life from an adult perspective.”

What About Legality and Safety?

  • Legal Status: In the U.S., MDMA therapy is not yet FDA-approved but has received “Breakthrough Therapy” status. Approval is expected by 2025.
  • Other Countries: Australia has already legalized it; Canada is moving in that direction.
  • Underground Therapy: Currently, access is limited to underground settings or clinical trials.

Key Insights

  • MDMA-assisted therapy may outperform traditional antidepressants for PTSD.
  • Proper screening and supervision are critical.
  • It is not addictive when used therapeutically.
  • Integration is essential for long-term healing.
  • Regulatory approval will likely accelerate global adoption.

Frequently Asked Questions (FAQ)

Is MDMA therapy legal?
Not yet in the U.S., but it has “Breakthrough Therapy” status and is legal in Australia.

Does MDMA cause hallucinations?
No. It’s an empathogen, not a hallucinogen. Users feel calm and emotionally open.

How many sessions are needed?
Typically 2–3 guided journeys, along with prep and integration sessions.

Can I do this while on antidepressants?
No. Most patients must taper off SSRIs or similar meds before starting MDMA therapy.

Similar Posts